Bide Pharmatech Co., Ltd. (SHA:688073)
China flag China · Delayed Price · Currency is CNY
51.99
-2.26 (-4.17%)
May 19, 2026, 4:00 PM EDT

Bide Pharmatech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,4795,2604,3425,0445,333-
Market Cap Growth
30.73%21.13%-13.91%-5.42%--
Enterprise Value
3,5364,3473,2603,9053,860-
Last Close Price
51.9961.0548.1752.7955.15-
PE Ratio
26.8934.6636.9846.0336.53-
Forward PE
19.6227.5631.7422.5030.12-
PS Ratio
3.323.973.944.626.40-
PB Ratio
2.132.572.142.412.57-
P/TBV Ratio
2.152.592.152.422.57-
P/FCF Ratio
126.091301.7962.06---
P/OCF Ratio
73.84185.6927.43-178.53-
EV/Sales Ratio
2.623.282.963.584.63-
EV/EBITDA Ratio
14.4121.5326.2635.8825.71-
EV/EBIT Ratio
16.4823.1628.8539.3326.74-
EV/FCF Ratio
99.541075.8146.59---
Debt / Equity Ratio
0.060.070.040.030.020.04
Debt / EBITDA Ratio
0.550.650.580.450.250.23
Debt / FCF Ratio
3.8134.921.18---
Net Debt / Equity Ratio
-0.45-0.44-0.54-0.58-0.71-0.26
Net Debt / EBITDA Ratio
-4.11-4.46-8.85-11.18-9.78-1.49
Net Debt / FCF Ratio
-26.55-222.86-15.7010.27172.021.76
Asset Turnover
0.520.540.460.460.510.86
Inventory Turnover
0.880.900.931.100.940.91
Quick Ratio
4.283.864.125.546.841.31
Current Ratio
7.436.746.398.229.013.28
Return on Equity (ROE)
8.12%7.45%5.71%5.21%10.79%19.65%
Return on Assets (ROA)
5.15%4.75%2.92%2.60%5.53%9.51%
Return on Invested Capital (ROIC)
14.66%14.06%9.95%11.55%22.92%25.82%
Return on Capital Employed (ROCE)
9.60%8.60%5.50%4.60%6.80%16.40%
Earnings Yield
3.75%2.89%2.70%2.17%2.74%-
FCF Yield
0.79%0.08%1.61%-2.35%-0.16%-
Dividend Yield
2.14%1.90%1.87%1.70%1.99%-
Payout Ratio
46.92%52.58%68.03%91.29%0.06%0.19%
Buyback Yield / Dilution
2.50%1.40%1.76%-22.83%-10.09%-8.03%
Total Shareholder Return
4.64%3.30%3.63%-21.13%-8.10%-8.03%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.